ERBB2 and glioblastoma: Over the years, researchers have identified unique markers in glioblastoma such as the epidermal growth factor receptor variant III (EGFRvIII), human epidermal growth factor receptor 2 (HER2) and IL-13 receptor alpha 2 (IL-13Rα2) as unique targets of CAR-T therapy.